Edit Bodolay
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research 13
-
- Systemic Sclerosis and Related Diseases 8
- Vitamin D Research Studies 6
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 4
- T-cell and B-cell Immunology 4
- Psoriasis: Treatment and Pathogenesis 3
- Dermatology top 10%
-
- Diabetes and associated disorders 3
-
- Vitamin C and Antioxidants Research 3
Edit Bodolay
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Rheumatology 477
- Pathology and Forensic Medicine 462
- Complementary and Manual Therapy 35
- Immunology 320
- Dermatology 60
Countries citing papers authored by Edit Bodolay
This map shows the geographic impact of Edit Bodolay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Bodolay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Bodolay more than expected).
Fields of papers citing papers by Edit Bodolay
This network shows the impact of papers produced by Edit Bodolay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Bodolay. The network helps show where Edit Bodolay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edit Bodolay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 11 | |
| 2 | 2014 | 11 | |
| 3 | 2013 | 35 | |
| 4 | 2013 | 38 | |
| 5 | 2013 | 70 | |
| 6 | Hazai konszenzus a D-vitamin szerepéről a betegségek megelőzésében és kezelésében | 2012 | 8 |
| 7 | 2011 | 31 | |
| 8 | 2010 | 22 | |
| 9 | 2010 | 48 | |
| 10 | 2009 | 22 | |
| 11 | 2008 | 7 | |
| 12 | 2008 | 97 | |
| 13 | 2006 | 11 | |
| 14 | 2005 | 141 | |
| 15 | 2005 | 14 | |
| 16 | 2004 | 2 | |
| 17 | 2002 | 93 | |
| 18 | Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. | 2000 | 44 |
| 19 | 1995 | 42 | |
| 20 | 1976 | 4 |
About Edit Bodolay
Edit Bodolay is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (13 papers), Systemic Sclerosis and Related Diseases (8 papers), Vitamin D Research Studies (6 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), T-cell and B-cell Immunology (4 papers), Diabetes and associated disorders (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Vitamin C and Antioxidants Research (3 papers). The work is most often cited by research in Rheumatology (477 citations), Pathology and Forensic Medicine (462 citations) and Complementary and Manual Therapy (35 citations). Edit Bodolay has collaborated with scholars based in Hungary, Norway and United States. Frequent co-authors include Gyula Szegedi, Zoltán Szekanecz, Margit Zeher, Péter Szodoray, Emese Kiss, Gabriella Szűcs, Éva Zöld, Britt Nakken, János Gaál and Katalin Dankó. Their work appears in journals such as Autoimmunity Reviews, The Journal of Rheumatology, Arthritis Research & Therapy, Clinical Rheumatology and Immunologic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.